Efficient and accurate testing solutions, so you can get back to business. Agilis offers discounted early booking packages and options that combine all of its UKAS accredited private provider tests.
Fit to Fly Tests are often required in case you need to travel to certain countries.
In order to come out of quarantine early you may need a Test to Release certificate
All international arrivals to the UK need to take Covid-19 tests
Kick start your business with accurate COVID-19 screening programme administered by healthcare professionals.
Get in TouchWe create solutions tailored to the needs of your business, whether your teams are remote or need to be office-based.
This test can indicate the presence of a live virus in an individual. These tests are great for early identification and stopping outbreaks.
We offer remote lab testing and point of care solutions. All testing machines and consumables are CE IVD accredited with high detection rates.
This is a highly accurate NHS standard swab test to identify if someone currently has COVID-19. Test samples are processed in a lab, which takes 12-18 hours to get the results.
A 10 minute test using a swab sample to identify if an individual has COVID-19. It requires no lab equipment and can be done on site.
Team members may have developed antibodies and should be tested before they can return to work.
This lab based test detects the presence of COVID-19 antibodies in the blood. These are Abbott ELISA based tests that have been approved by NHS for testing of antibodies.
As part of our offering, we are able to peform local antibody tests in empty office spaces using portable equipment. These are quick tests that last only 12-20 minutes.
Use the portal to understand your risk exposure and track symptoms of your staff and/or visitors.
Get regular updates and view how many of your staff have symptoms, are high risk, have had the virus and developed antibodies or have tested positive.
One way to reduce risk is to get more data and facts. Through the portal, you are able to request swab tests or antibody tests and automatically receive results as soon as they become available.
Where available, we are able to integrate with your HR systems or provide bolt-on track & trace solution to give better visibility and risk management.
We offer a tailored, integrated solution to help businesses reopen safely, with additional high quality services.
At Agilis, our research team use trends and developments from the UK and beyond to make informed and aware decisions. We have worked with businesses in the South Korean biotech industry for a number of years and have crafted close working relationships. Businesses in this sector are globally renowned for delivering consistently high quality, reliable products and we are proud of our links to the industry.
We believe that our end to end solution is the most comprehensive in terms of helping companies get back to business as usual.
All international arrivals into the UK who are not fully vaccinated will need to quarantine for 10 days on arrival and take covid-19 tests on or before day 2 and on or after day 8.
For all international arrivals into the UK who are fully vaccinated will need to take a covid-19 test on or before day 2 upon arrival and will not need to quarantine.
Before an individual who isn’t fully vaccinated travels to the UK, they must:
For more information and guidance please visit: https://www.gov.uk/guidance/how-to-quarantine-when-you-arrive-in-england
Monday to Friday
For bookings received before 3pm, the sample packs will be sent out same day, for next day delivery
Saturday
For bookings received before 11am, sample packs will be sent out same day, for delivery on Monday.
For bookings received after 11am on Saturday, and/or on Sunday, sample packs will be sent out on Monday, for delivery on Tuesday.
If your requirement is urgent, alternative fast track delivery options can be arranged for an additional fee, including private courier.
Please call Agilis Customer Service on 01592 269570 or email: help@agilishealth.co.uk for more information
There are two main types of test:
Antigen Test: this tests for the presence of a virus in a sample. There are ranges of tests in this category from ‘gold standard’ tests that are done by an accredited lab to more of screening solutions that require little to no equipment and are able to provide results in 8-30 minutes
Antibody Tests: this tests whether someone has developed antibodies and had the virus previously.
There are two different types of Antibody tests:
1) Lab based Antibody test- a test kit is used to gather blood from a patient which is then tested in the lab. These are usually referred to as ELISA tests. They are extremely accurate and able to let you know if you had the virus and developed antibodies as a result of this.
2) Blood prick tests- these test kits can be used by trained professional to determine at point of care whether you had the virus. A small blood prick is taken and used in a cartridge to do the diagnostic.
Yes, we provide a number of solutions from regular lab based testing to developing regular screening programmes.
In the first instance we propose designing and agreeing clinical governance approach to workplace testing and then we provide a solution to support this.
Yes, we have a number of remote solutions if you decide you only want to do ad-hoc testing.
Current mutation of SARS Cov-2: D614G SARS COV-2
Mutated position by SNPs (single nucleotide polymorphism)
Nucleotide change at 23,403 base of RNA from adenosine (A) to guanine (G)
Mutated at D614 on the Spike Protein (SP)
enhancing the binding affinity to ACE2 receptor
no mutation on the nucleocapid protein (NP) of Sars Cov-2
In summary this has no impact on our ability to successfully detect covid-19
The Agilis Health refund policy is as follows:
Please note if you are booking Test to Release, the earliest that the sample can be collected is during the course of day 5 of your quarantine, with day 1 commencing from the time that you arrive in the UK. This means that you are able to book a test on day 1 of quarantine, get pack in time and arrange a video call appointment for day 5. This would allow us to get the sample to the lab the day following your test and then issue your result typically within 12-18 hours of it getting to the lab (guaranteed within 24 hours of the sample getting to the lab).
Many governments and airlines require that a test for COVID-19 be taken prior to travelling. The rules differ by government and airline and some accept antigen tests, some only accept PCR tests and there is little consistency as to the timeline requirement for the test result, but typically it is 48-72 hours prior to travel. Please check specific requirements prior to booking the Fit to Fly test.
Typically Agilis operates a home service. Our service includes a video call with one of our nurses that is able to guide you through the sample collection process. As such we are able to offer our service nationwide.
Please note that if you are travelling to the UK from a country on the red list, then you are not eligible to opt into the Test to Release scheme.
You can see the red list on this link: Coronavirus (COVID-19): red list travel ban countries – GOV.UK (www.gov.uk)
From 4am on 9th January, should you be travelling to the UK from Namibia, Zimbabwe, Botswana, Eswatini, Zambia, Malawi, Lesotho, Mozambique, Angola, Mauritius or Seychelles, then as per government advice you should self-isolate for 10 days upon entry to the UK and should not take a test to release test during this period.
In addition, from 4am on 15th January, should you be travelling to the UK from Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela, Cape Verde, Portugal (including Madeira and the Azores) and Panama, then as per government advice you should self-isolate for 10 days upon entry to the UK and should not take a test to release test during this period.
As of 4am on 29th January, the same travel restrictions as above will apply for Burundi, UAE and Rwanda and anyone who has travelled from any of these countries should not participate in the test to release scheme.
